|

DRAGON Registry - International Multicenter Registry and Medical Image Bank for Patients With Primarily Unresectable Liver Cancer or Liver Metastases That Underwent Combined Portal and Hepatic Vein Embolization (PVE/HVE) to Increase Future Liver Remnant Before Resection.

RECRUITINGSponsored by Maastricht University Medical Center
Actively Recruiting
SponsorMaastricht University Medical Center
Started2021-03-16
Est. completion2027-11-30
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations3 sites

Summary

The DRAGON registry aims to collect data on combined portal and hepatic vein embolization (PVE/HVE) for liver tumors, a technique expected to enhance liver regeneration compared to standard PVE. This collaborative registry focuses on identifying associations between baseline clinical/imaging parameters, clinical outcomes, and safety for patients undergoing PVE/HVE.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Patients who have undergone PVE/HVE or technical variations on this procedure
* 18 Years and older
* Men and women

Conditions4

CancerLiver CancerLiver DiseaseLiver Metastases

Locations3 sites

Illinois

1 site
Rush University Medical Center
Frannie Richards+1 312-942-5000frannie_l_richards@rush.edu

Minnesota

1 site
Mayo Clinic
Rochester, Minnesota, 55905
Yawen Dong, Dr.+1 507-284-2511InternationalCollaborate@mayo.edu

Ohio

1 site
Cleveland Clinic
Cleveland, Ohio, 44195
Federico Aucejo, Dr.+1 216-444-2200patientexperienceccl@ccf.org

Find trials near these locations

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.